Merck (MRK) Accumulated Expenses (2009 - 2011)

Merck (MRK) has reported Accumulated Expenses for 3 consecutive years, with $8.6 billion the latest figure, recorded in Q1 2011.

• On a quarterly basis, Accumulated Expenses rose 1.37% year-over-year to $8.6 billion in Q1 2011; TTM through Mar 2011 was $8.6 billion, a 1.37% increase from a year earlier, with the FY2010 full-year figure at $8.5 billion, down 9.95% from the prior year.
• Accumulated Expenses was $8.6 billion for Q1 2011 at Merck, roughly flat from $8.5 billion in the prior quarter.
• Over five years, Accumulated Expenses peaked at $9.5 billion in Q4 2009 and troughed at $828.0 million in Q2 2009.
• A 3-year average of $6.5 billion and a median of $8.3 billion in 2010 frame the typical range for Accumulated Expenses.
• The widest YoY moves for Accumulated Expenses: up 743.8% in 2010, down 9.95% in 2010.
• Over 3 years, Accumulated Expenses stood at $9.5 billion in 2009, then dropped by 9.95% to $8.5 billion in 2010, then gained by 0.48% to $8.6 billion in 2011.
• The last three Accumulated Expenses figures came in at $8.6 billion (Q1 2011), $8.5 billion (Q4 2010), and $8.2 billion (Q3 2010), per Business Quant data.